• SELECT SITE CURRENCY
Select a currency for use throughout the site
Global Human Papillomavirus Testing Market 2011-2015
Infiniti Research Limited, June 2012, Pages: 34
TechNavio's analysts forecast the Global Human Papillomavirus Testing market to grow at a CAGR of 19.5 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing number of Human Papillomavirus (HPV) cases. The Global Human Papillomavirus Testing market has also been witnessing the trend of increasing the number of mergers and acquisitions. However, lack of sufficient healthcare organizations could pose a challenge to the growth of this market.
TechNavio's report, the Global Human Papillomavirus Testing Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Human Papillomavirus Testing market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this market space include Gen-Probe Inc., Hologic Inc., Roche Diagnostic Inc., and QIAGEN N.V.
Key questions answered in this report:
- What will the market size be in 2015 and at what rate will it grow?
- What key trends is this market subject to?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the opportunities and threats faced by each of these key vendors?
- What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of analyst time when you purchase this report. Details provided within the report.
TechNavio Announces the Publication of its Report - Global Human Papillomavirus Testing Market 2011-2015
TechNavio today launched its report Global Human Papillomavirus Testing Market 2011-2015 based on an in-depth study covering the Americas, and the EMEA and APAC regions. The report aims to aid decision makers and understanding of the key trends impacting this market.
Commenting on the report, an analyst from TechNavio's Healthcare team said; 'The Global Human Papillomavirus (HPV) Testing market is witnessing several mergers and acquisitions among the leading vendors in the market. Vendors are using the mergers and acquisitions strategy to increase their global presence, and to increase their product portfolio. This strategy helps vendors to focus better through collaborations and thereby increase their profit margins. This is one of the major factors fuelling the growth of the Global HPV Testing market.'
According to the report, the vendors in the Global HPV Testing market have developed innovative products that could provide quick and accurate HPV test results and can be used at home. Therefore, with the introduction of rapid HPV test kits in the market, quick test kits provide several opportunities to dramatically increase the number of people taking HPV tests. Thus, the availability of home HPV testing kits is one of the major factors contributing to the growth of the Global HPV Testing market.
Further, the report also discusses that one of the key challenges in the Global HPV Testing market is the lack of enough healthcare organizations to conduct HPV tests.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key players.
01. Executive Summary
03. Market Coverage
04. Market Landscape
Five Forces Analysis
05. Geographical Segmentation
06. Key Leading Countries
07. Rate of Incidence and Prevalence
08. Vendor Landscape
Product Offerings in the Global Human Papillomavirus Market
09. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Key Vendor Analysis
15.1 Gen-Probe Inc.
15.2 Hologic Inc.
15.3 Roche Diagnostics Inc.
15.4 QIAGEN N.V.
16. Other Reports in this Series
List of Exhibits:
Exhibit 1: Global Human Papillomavirus Market 2011-2015 (US$ million)
Exhibit 2: Global Human Papillomavirus Market by Geographical Segmentation 2011
Exhibit 3: Global Human Papillomavirus Testing Market by Vendor Segmentation-2011